Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Clinical trial NCT06547216 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06547216
Sponsor: Avidity Biosciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

FSHD FSHD1 FSHD2 FMD FMD2 Fascioscapulohumeral Muscular Dystrophy Fascioscapulohumeral Muscular Dystrophy Type 1 Fascioscapulohumeral Muscular Dystrophy Type 2 Dystrophies, Facioscapulohumeral Muscular Dystrophy, Facioscapulohumeral Muscular Facioscapulohumeral Muscular Dystrophy 1 Facioscapulohumeral Muscular Dystrophy 2

Start date: 2024-07-25
Primary completion: 2030-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.